Development of a human IgA antibody specific for the tumour antigen TAG-72.
Ingram
P E
PE
Department of Molecular & Cellular Pathology, University of Dundee Medical School, Ninewells Hospital, U.K.
Owens
R J
RJ
Woof
J M
JM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis* / Q000627:therapeutic use; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000276:immunology*; D000970:Antineoplastic Agents; D016466:CHO Cells; D019556:COS Cells; D006224:Cricetinae; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000096:biosynthesis* / Q000627:therapeutic use; D007143:Immunoglobulin Heavy Chains / Q000096:biosynthesis; D007147:Immunoglobulin Light Chains / Q000096:biosynthesis; D051379:Mice; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis*; D014162:Transfection
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D006023:Glycoproteins; D007070:Immunoglobulin A; D007143:Immunoglobulin Heavy Chains; D007147:Immunoglobulin Light Chains; D011993:Recombinant Fusion Proteins; C047052:tumor-associated antigen 72